Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression | Citedby Results | Archives of Pathology & Laboratory Medicine

Skip to Main Content

Skip Nav Destination

Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression

Arch Pathol Lab Med (2024) 148 (2): 242–255.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Interpreting HER2-low at the lower end: Added challenge to the pathologists

Thaer Khoury

Annals of Diagnostic Pathology (2024) 70: 152291.

Interobserver Variability in HER‐2 Immunostaining Interpretation of Metastatic HER2 Low Breast Cancers in Cytology Specimens

Niyati Desai
Courtney F. Connelly
Simon Sung
Adela Cimic
Swikrity U. Baskota

Diagnostic Cytopathology (2024) 52 (12): 722.

A Comparative Analysis of the Value of HER2 Immunohistochemistry Scoring in Primary and Metastatic Breast Cancer, in the Era of HER2 “Low” Breast Cancers

Swati Bhardwaj
Shabnam Jaffer

Clinical Breast Cancer (2024)

A Nationwide Study on HER2-Low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols

Min Chong Kim
Eun Yoon Cho
So Yeon Park
Hee Jin Lee
Ji Shin Lee
Jee Yeon Kim
Ho-chang Lee
Jin Ye Yoo
Hee Sung Kim
Bomi Kim
Wan Seop Kim
Nari Shin
Young Hee Maeng
Hun Soo Kim
Sun Young Kwon
Chungyeul Kim
Sun-Young Jun
Gui Young Kwon
Hye Jeong Choi
So Mang Lee
Ji Eun Choi
Ae Ri An
Hyun Joo Choi
EunKyung Kim
Ahrong Kim
Ji-Young Kim
Jeong Yun Shim
Gyungyub Gong
Young Kyung Bae

Cancer Research and Treatment (2024) 56 (4): 1096.

Human Epidermal Growth Factor Receptor 2 “Low” in Breast Cancer in 2023

Shabnam Jaffer

Archives of Pathology & Laboratory Medicine (2023) 147 (9): 989.